“CARDIOVASCULAR RISK FEATURES IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) DEPENDING ON THE PRESENCE OF OBESITY”. International Journal of Medical Sciences, vol. 5, no. 05, June 2025, pp. 396-03, https://doi.org/10.55640/.